Source: Rheumatology International. Unidades: FCFRP, FMRP
Subjects: METOTREXATO, NEUTRÓFILOS, ARTRITE REUMATOIDE, ANTICORPOS MONOCLONAIS
ABNT
MARCHI, Larissa F. et al. Activation status of peripheral blood neutrophils and the complement system in adult rheumatoid arthritis patients undergoing combined therapy with infliximab and methotrexate. Rheumatology International, v. 38, n. 6, p. 1043-1052, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00296-018-3997-1. Acesso em: 10 nov. 2024.APA
Marchi, L. F., Paschoalato, A. B. P., Oliveira, R. D. R. de, Azzolini, A. E. C. S., Kabeya, L. M., Donadi, E. A., & Lucisano-Valim, Y. M. (2018). Activation status of peripheral blood neutrophils and the complement system in adult rheumatoid arthritis patients undergoing combined therapy with infliximab and methotrexate. Rheumatology International, 38( 6), 1043-1052. doi:10.1007/s00296-018-3997-1NLM
Marchi LF, Paschoalato ABP, Oliveira RDR de, Azzolini AECS, Kabeya LM, Donadi EA, Lucisano-Valim YM. Activation status of peripheral blood neutrophils and the complement system in adult rheumatoid arthritis patients undergoing combined therapy with infliximab and methotrexate [Internet]. Rheumatology International. 2018 ; 38( 6): 1043-1052.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s00296-018-3997-1Vancouver
Marchi LF, Paschoalato ABP, Oliveira RDR de, Azzolini AECS, Kabeya LM, Donadi EA, Lucisano-Valim YM. Activation status of peripheral blood neutrophils and the complement system in adult rheumatoid arthritis patients undergoing combined therapy with infliximab and methotrexate [Internet]. Rheumatology International. 2018 ; 38( 6): 1043-1052.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s00296-018-3997-1